•
Dec 31, 2024

Milestone Pharmaceuticals Q4 2024 Earnings Report

Expected Revenue:$0
Expected EPS:-$0.15
+50.0% YoY
Total Revenue
$0
Previous year: -$868K
-100.0%
Gross Profit
-$567K
Previous year: -$1.4M
-59.5%
Cash and Equivalents
$69.7M
Previous year: $66M
+5.6%
Free Cash Flow
-$6.36M
Previous year: -$9.25M
-31.2%
Total Assets
$75.5M
Previous year: $75.2M
+0.4%

Milestone Pharmaceuticals

Milestone Pharmaceuticals